Gregg S. Levin

Open for Business
Gregg S. Levin: Attorney with Motley Rice LLC

Biography

With more than three decades of legal experience, Gregg Levin represents domestic and foreign institutional investors and union pension funds in corporate governance, directorial misconduct and securities fraud matters.

Gregg's investigative, research and writing skills have supported Motley Rice as lead or co-lead counsel in numerous securities and shareholder derivative actions, including cases involving HP, Avon, and Cintas Corporation. Gregg manages complaint and brief writing for class action deal cases, shareholder derivative suits and securities fraud class actions.

Prior to joining Motley Rice, Gregg represented institutional investors in securities fraud actions and shareholder derivative actions in federal and state courts across the country, including the WorldCom, Telxon and Global Crossing cases. He also served as corporate counsel to a Delaware Valley-based retail corporation from 1996-2003, where he handled corporate compliance matters and internal investigations.

In 2019, Gregg was appointed as a Vice President of the Institute for Law and Economic Policy, a foundation whose goals include supplementing the resource-limited SEC by educating the public on the importance of private securities fraud litigation in maintaining corporate accountability. Since its inception in the 1990s, the institute has presented and published papers that have been cited in more than 60 federal cases, including several in the U.S. Supreme Court. Appearing in the media to discuss a variety of securities matters, Gregg has also presented in educational forums, including at the Ethics and Transparency in Corporate America Webinar held by the National Association of State Treasurers.

Published Works

Gregg is a published author on corporate governance and accountability issues, having written significant portions of the treatise Shareholder Activism Handbook (Aspen Publishers, November 2005), as well as several other articles of interest to institutional investors, including:

•'In re Cox Communications: A Suggested Step in the Wrong Direction' (Bank and Corporate Governance Law Reporter, September 2005)
•'Does Corporate Governance Matter to Investment Returns?' (Corporate Accountability Report, September 23, 2005)
•'In re Walt Disney Co. Deriv. Litig. and the Duty of Good Faith under Delaware Corporate Law' (Bank and Corporate Governance Law Reporter, September 2006)
•'Proxy Access Takes Center Stage: The Second Circuit's Decision in American Federation of State County and Municipal Employees, Employees Pension Plan v. American International Group, Inc.' (Bloomberg Law Reports, February 5, 2007)
•'Investor Litigation in the U.S. -- The System is Working' (Securities Reform Act Litigation Reporter, February 2007)

Awards, Accolades & Recognitions

Lawdragon

2019 Lawdragon 500 Plaintiff Financial Lawyers

Law360

2022 'Securities MVP'

South Carolina Lawyers Weekly

2022 Leadership in Law Honoree

Best Lawyers

2024-2026 Mass tort litigation / class actions-plaintiffs

Blog Posts

October 30, 2013

Supreme Court case to watch: SLUSA application Causes, Not Just Cases

by: Gregg S. Levin

News

April 28, 2025

The history and legacy of Workers’ Memorial Day

by:
M. Nolan Webb

August 26, 2024

51 Motley Rice attorneys listed in 2025 Best Lawyers in America guide

by: Motley Rice

See more ›

Areas of Practice (2)

  • Securities Class Actions
  • Whistleblower

Education & Credentials

University Attended:
University of Rochester, B.A., magna cum laude, 1984
Law School Attended:
Vanderbilt University School of Law, J.D., 1987
Year of First Admission:
1987
Admission:
District of Columbia; Massachusetts; South Carolina; U.S. Court of Appeals for the First, Second, Third, Fourth, Fifth, Sixth, Seventh, Ninth and Eleventh Circuits; U.S. District Court for the District of Colorado, Northern District of Illinois, District of Massachusetts, and the Eastern District of Michigan
Memberships:

Associations

•Institute for Law and Economic Policy, Vice President

Reported Cases:
CaseWork: Alexion Securities Class Action Lawsuit - Settlement: Securities Class Actions; Motley Rice, as co-lead counsel, has negotiated a $125 million settlement to resolve securities class action claims brought on behalf of certain investors in Alexion Pharmaceuticals, Inc. The action, which was commenced in late 2016 in...; Foreign Corrupt Practices Violations: Avon Products, Inc.: Securities Class Actions; Motley Rice represented the lead plaintiffs and was appointed sole lead counsel in the class action suit City of Brockton Retirement Systems v. Avon Products, Inc., filed for investors who acquired Avon common stock during the class...; Controlled Substances Violations: Walgreen Co.: Securities Class Actions; A corporate governance reform settlement was reached between Walgreen Co. ('Walgreens'), members of the company's board of directors, and several institutional investors following federal fines against the company for allegedly...; Shareholder Derivative Lawsuit: Securities Class Actions Antitrust; Through shareholder derivative actions, we work with company investors to restore value lost to the company due to willful mismanagement, insider self-dealing or other acts of malfeasance.; Securities Fraud: Securities Class Actions Antitrust; Representing domestic and foreign institutional investors-including union, pension, and hedge funds-in recovering shareholder losses incurred due to corporate fraud.; Anti-Kickback Regulation: Omnicare, Inc.: Securities Class Actions; Manville Personal Injury Trust filed a shareholder derivative complaint against Omnicare, Inc., in 2010 for participating in illegal kickback schemes, necessitating new corporate governance measures.; Missed Earnings Projections: Hewlett Packard: Securities Class Actions; HP settled for $57 million in this securities fraud case alleging that the company did not fulfill promises of new webOS technology, causing stock prices to drop.; Clinical Trial Complications: Pharmacia Corp: Securities Class Actions; A $164 million settlement was reached with Pharmacia Corp. et al in this securities fraud case regarding alleged misleading statements concerning the safety profile of anti-inflammatory drug, Celebrex.
ISLN:
905493242

Payment Information

Other Information
Free initial consultation

Peer Reviews

This lawyer does not have peer reviews.

Client Reviews Write a Review

Location

Contact Gregg S. Levin

Contact Information:

843-216-9450  Fax

www.motleyrice.com/attorneys/gregg-s-levin

Required Fields

Required Fields

Clear All Fields

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.